Literature DB >> 8909261

Expression of human endogenous retrovirus K elements in germ cell and trophoblastic tumors.

H Herbst1, M Sauter, N Mueller-Lantzsch.   

Abstract

Antibodies against proteins encoded by human endogenous retrovirus (HERV)-K family genes are consistently found in the sera of patients with classical seminoma. Furthermore, HERV-K Gag-encoded protein could be detected in corresponding tumor biopsies. Addressing questions as to the extent of HERV gene expression in biologically related lesions, we studied various testicular and ovarian germ cell tumors (GCTs), GCT precursor lesions, and gestational trophoblastic disease (GTD) for the presence of HERV-K gene transcripts in tissue sections. By in situ hybridization using four non-overlapping, isotopically labeled RNA probes specific for HERV-K gag and env sequences on archival tissue samples, consistent HERV-K expression of gag and env genes was found to be common to all GCTs and their testicular precursor lesions with the exception of teratomas, mature and immature, and spermatocytic seminomas. HERV-K expression was also found in malignant GTD (choriocarcinoma) but not in benign GTD (noninvasive molar pregnancy). There was no evidence for HERV-K expression in differentiated embryonal and adult tissues as well as a total of 53 tumors other than GCT or GTD. The findings point to a common molecular pathoetiology of GCT and malignant GTD, have implications for the classification of GCTs, and support the concept of carcinoma in situ as a precursor lesion common to all forms of testicular GCT.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8909261      PMCID: PMC1865275     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  15 in total

1.  Distribution and phenotype of Epstein-Barr virus-harboring cells in Hodgkin's disease.

Authors:  H Herbst; E Steinbrecher; G Niedobitek; L S Young; L Brooks; N Müller-Lantzsch; H Stein
Journal:  Blood       Date:  1992-07-15       Impact factor: 22.113

2.  In situ hybridization for procollagen types I, III and IV mRNA in normal and fibrotic rat liver: evidence for predominant expression in nonparenchymal liver cells.

Authors:  S Milani; H Herbst; D Schuppan; E G Hahn; H Stein
Journal:  Hepatology       Date:  1989-07       Impact factor: 17.425

3.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

Authors:  H Towbin; T Staehelin; J Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

4.  Possible carcinoma-in-situ of the testis.

Authors:  N E Skakkebaek
Journal:  Lancet       Date:  1972-09-09       Impact factor: 79.321

5.  Induction of retrovirus particles in human testicular tumor (Tera-1) cell cultures: an electron microscopic study.

Authors:  D L Bronson; E E Fraley; J Fogh; S S Kalter
Journal:  J Natl Cancer Inst       Date:  1979-08       Impact factor: 13.506

6.  Cloned human and mouse kappa immunoglobulin constant and J region genes conserve homology in functional segments.

Authors:  P A Hieter; E E Max; J G Seidman; J V Maizel; P Leder
Journal:  Cell       Date:  1980-11       Impact factor: 41.582

7.  Carcinoma-in-situ of the testis: possible origin from gonocytes and precursor of all types of germ cell tumours except spermatocytoma.

Authors:  N E Skakkebaek; J G Berthelsen; A Giwercman; J Müller
Journal:  Int J Androl       Date:  1987-02

8.  Nucleotide sequence of human endogenous retrovirus genome related to the mouse mammary tumor virus genome.

Authors:  M Ono; T Yasunaga; T Miyata; H Ushikubo
Journal:  J Virol       Date:  1986-11       Impact factor: 5.103

Review 9.  [Carcinoma in situ of the testis: clinical significance, diagnosis and therapy].

Authors:  K P Dieckmann; V Loy; H Huland
Journal:  Urologe A       Date:  1989-09       Impact factor: 0.639

10.  Human endogenous retrovirus K10: expression of Gag protein and detection of antibodies in patients with seminomas.

Authors:  M Sauter; S Schommer; E Kremmer; K Remberger; G Dölken; I Lemm; M Buck; B Best; D Neumann-Haefelin; N Mueller-Lantzsch
Journal:  J Virol       Date:  1995-01       Impact factor: 5.103

View more
  33 in total

1.  Np9 protein of human endogenous retrovirus K interacts with ligand of numb protein X.

Authors:  Vivienne Armbruester; Marlies Sauter; Klaus Roemer; Barbara Best; Steffen Hahn; Achille Nty; Andreas Schmid; Stephan Philipp; Anja Mueller; Nikolaus Mueller-Lantzsch
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

2.  Detection of human endogenous retrovirus type K-specific transcripts in testicular parenchyma and testicular germ cell tumors of adolescents and adults: clinical and biological implications.

Authors:  H Roelofs; R J van Gurp; J W Oosterhuis; L H Looijenga
Journal:  Am J Pathol       Date:  1998-10       Impact factor: 4.307

3.  Comprehensive analysis of human endogenous retrovirus transcriptional activity in human tissues with a retrovirus-specific microarray.

Authors:  Wolfgang Seifarth; Oliver Frank; Udo Zeilfelder; Birgit Spiess; Alex D Greenwood; Rüdiger Hehlmann; Christine Leib-Mösch
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

4.  ERV3 and related sequences in humans: structure and RNA expression.

Authors:  Ann-Catrin Andersson; Zhihong Yun; Göran O Sperber; Erik Larsson; Jonas Blomberg
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

5.  Vaccination with cancer- and HIV infection-associated endogenous retrotransposable elements is safe and immunogenic.

Authors:  Jonah B Sacha; In-Jeong Kim; Lianchun Chen; Jakir H Ullah; David A Goodwin; Heather A Simmons; Daniel I Schenkman; Frederike von Pelchrzim; Robert J Gifford; Francesca A Nimityongskul; Laura P Newman; Samantha Wildeboer; Patrick B Lappin; Daisy Hammond; Philip Castrovinci; Shari M Piaskowski; Jason S Reed; Kerry A Beheler; Tharsika Tharmanathan; Ningli Zhang; Sophie Muscat-King; Melanie Rieger; Carla Fernandes; Klaus Rumpel; Joseph P Gardner; Douglas H Gebhard; Juliann Janies; Ahmed Shoieb; Brian G Pierce; Dusko Trajkovic; Eva Rakasz; Sing Rong; Michael McCluskie; Clare Christy; James R Merson; R Brad Jones; Douglas F Nixon; Mario A Ostrowski; Peter T Loudon; Ingrid M Pruimboom-Brees; Neil C Sheppard
Journal:  J Immunol       Date:  2012-06-27       Impact factor: 5.422

Review 6.  Human endogenous retrovirus-K (HML-2): a comprehensive review.

Authors:  Marta Garcia-Montojo; Tara Doucet-O'Hare; Lisa Henderson; Avindra Nath
Journal:  Crit Rev Microbiol       Date:  2018-10-14       Impact factor: 7.624

Review 7.  HERVs in neuropathogenesis.

Authors:  Tove Christensen
Journal:  J Neuroimmune Pharmacol       Date:  2010-04-27       Impact factor: 4.147

8.  Structure and phylogenetic analysis of an endogenous retrovirus inserted into the human growth factor gene pleiotrophin.

Authors:  A M Schulte; A Wellstein
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

9.  Human endogenous retrovirus family HERV-K(HML-2) RNA transcripts are selectively packaged into retroviral particles produced by the human germ cell tumor line Tera-1 and originate mainly from a provirus on chromosome 22q11.21.

Authors:  Klemens Ruprecht; Humberto Ferreira; Aline Flockerzi; Silke Wahl; Marlies Sauter; Jens Mayer; Nikolaus Mueller-Lantzsch
Journal:  J Virol       Date:  2008-08-06       Impact factor: 5.103

10.  Human endogenous retrovirus HERV-K(HML-2) encodes a stable signal peptide with biological properties distinct from Rec.

Authors:  Alessia Ruggieri; Esther Maldener; Marlies Sauter; Nikolaus Mueller-Lantzsch; Eckart Meese; Oliver T Fackler; Jens Mayer
Journal:  Retrovirology       Date:  2009-02-16       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.